Liposic

Carbomer, the active ingredient in Liposic, is an excipient presented as an ophthalmic vehicle for ocular use. It functions as a viscosity enhancer and stabilizer, helping to maintain the consistency, clarity, and sterility of eye drop formulations.

GNH USA supplies Liposic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, ensuring quality manufacturing, regulatory adherence, and reliable global distribution. The company also provides technical support and documentation to meet local health authority requirements.

Liposic, containing carbomer, is used as a viscosity enhancer in ophthalmic formulations.

Dry eye syndrome: improves retention and spreading of lubricating eye drops. Post‑surgical eye care: stabilizes postoperative ophthalmic solutions for better comfort. Allergic conjunctivitis: enhances uniform distribution of anti‑inflammatory eye drops.

Carbomer‑based ophthalmic vehicles are generally well tolerated, but some adverse reactions may occur.

Common Side Effects: - Ocular irritation or stinging upon instillation. - Transient blurred vision. - Redness of the conjunctiva. - Excessive tearing. - Mild allergic conjunctivitis. - Temporary foreign‑body sensation.

Serious or Rare Side Effects: - Severe allergic reaction or anaphylaxis. - Corneal ulceration. - Significant increase in intra‑ocular pressure. - Persistent ocular edema. - Vision loss. - Endophthalmitis.

When using Liposic, consider the following precautions.

Assess patient for known hypersensitivity: avoid if allergic to carbomer or related polymers. Monitor ocular tolerance: watch for irritation or redness. Avoid use in compromised corneal epithelium unless advised by a specialist. Do not combine with incompatible ophthalmic solutions without compatibility testing. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Carbomer may interact with certain ophthalmic agents.

Major Interactions (Avoid): - Concurrent use with ophthalmic solutions containing high concentrations of cationic preservatives: may cause precipitation. - Co‑administration with other viscosity‑enhancing agents: risk of gel formation.

Moderate Interactions (Monitor Closely): - Use with topical anesthetics: may increase ocular surface irritation. - Use with anti‑inflammatory eye drops: monitor for altered drug release. - Use with contact lenses: may cause lens deposits.